Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MIAT
   Synonyms MIAT, C22orf35, GOMAFU, LINC00066, NCRNA00066, RNCR2, lncRNA-MIAT, FLJ25967
   Region GRCh38_22:26646428-26676475    Sequence
   Ensembl ENSG00000225783
   RefSeq NR_003491
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name hepatocellular carcinoma
   ICD-0-3 C22.0  M8170/3
   Methods qPCR, Western blot, RNAi etc.
   Sample hepatocellular carcinoma tissues, cell lines (HepG2, Huh7, SK-HEP-1, HLE and L02)
   Expression Pattern up-regulated
   Function Description

Upregulation of MIAT is related to the proliferation and invasion of HCC,and downregulating MIAT expression inhibited HCC cell proliferation and invasion.The H3/H4 histone acetylation level of MIAT promoter in HCC tissues was higher than that in normal tissues.MIAT negatively regulated miR-214 in HCC cells. Inhibition of miR-214 reversed the influence of MIAT downregulation on HCC cell proliferation and invasion.In nude mouse xenograft models,downregulation of MIAT markedly suppressed the tumor growth of HCC via releasing miR-214.In conclusion, lncRNA MIAT promotes the proliferation and invasion of HCC cells through sponging miR-214, which brings a novel target for the therapy and prognosis of hepatocellular carcinoma.NEW & NOTEWORTHY This is the first research showing long noncoding RNA (lncRNA) myocardial infarction-associated transcript (MIAT) to have a regulatory effect on hepatocellular carcinoma.

   Pubmed ID 29097358
   Year 2018
   Title lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
   External Links
   Links for  MIAT GenBank       HGNC       lncrnadb       Noncode
   Links for  hepatocellular carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.